Compile Data Set for Download or QSAR
Report error Found 90 Enz. Inhib. hit(s) with all data for entry = 13590
TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808969BDBM808969(US12637469, Compound 10)
Affinity DataIC50: 11nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 12nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808964BDBM808964(US12637469, Compound 5)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808964BDBM808964(US12637469, Compound 5)
Affinity DataIC50: 19nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808968BDBM808968(US12637469, Compound 9)
Affinity DataIC50: 22nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808968BDBM808968(US12637469, Compound 9)
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808967BDBM808967(US12637469, Compound 8)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808963BDBM808963(US12637469, Compound 2)
Affinity DataIC50: 31nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808967BDBM808967(US12637469, Compound 8)
Affinity DataIC50: 31nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808966BDBM808966(US12637469, Compound 7)
Affinity DataIC50: 34nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808970BDBM808970(US12637469, Compound 11)
Affinity DataIC50: 34nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808969BDBM808969(US12637469, Compound 10)
Affinity DataIC50: 41nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808966BDBM808966(US12637469, Compound 7)
Affinity DataIC50: 42nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808965BDBM808965(US12637469, Compound 6)
Affinity DataIC50: 44nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetCytochrome P450 1A2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetCytochrome P450 2C9(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808965BDBM808965(US12637469, Compound 6)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetCytochrome P450 2C19(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetCytochrome P450 2D6(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetCytochrome P450 3A4(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808970BDBM808970(US12637469, Compound 11)
Affinity DataIC50: 56nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4)(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 63nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808971BDBM808971(US12637469, Compound 12)
Affinity DataIC50: 88nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 91nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetVascular endothelial growth factor receptor 1 (Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 104nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetHigh affinity nerve growth factor receptor (TrkA)(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 112nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 117nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808963BDBM808963(US12637469, Compound 2)
Affinity DataIC50: 125nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase JAK2(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 141nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase ABL1(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 152nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase Yes(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 204nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase TXK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 227nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetAurora kinase B(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 232nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetMitogen-activated protein kinase 10(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 279nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase SYK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808971BDBM808971(US12637469, Compound 12)
Affinity DataIC50: 315nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 367nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase Fyn(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 373nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetCasein kinase I isoform epsilon(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 385nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase HCK(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 418nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetFocal adhesion kinase 1(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 469nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetRho-associated protein kinase 2 (ROCK2)(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 499nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase JAK3(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase JAK1(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 663nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 756nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetProtein BRICK1(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 775nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase Src [1-530](Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 827nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetFibroblast growth factor receptor 1(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 847nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

TargetTyrosine-protein kinase Lyn(Human)
Ocumension Therapeutics (Suzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 808962BDBM808962(US12637469, Compound 1)
Affinity DataIC50: 934nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: